This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Kyle Gano
Chief Business Development and Strategy Officer at Neurocrine Biosciences (NASDAQ: NBIX)


Dr. Kyle Gano, Chief Business Development and Strategy Officer, is responsible for business and corporate development activities, including the management of ongoing collaborations with AbbVie, BIAL, Mitsubishi Tanabe Pharma, and Voyager Therapeutics. Since joining Neurocrine Biosciences in 2001, Dr. Gano has held several positions of increasing responsibility across functions spanning marketing analytics to business development. Dr. Gano holds a Ph.D. in Organic Chemistry and a M.B.A. in Finance from the University of California, Los Angeles, a B.S. in Chemistry from the University of Oregon, and a B.S. in Biochemistry from the University of Washington.

Agenda Sessions

  • CNS: Following the innovation

    On Demand

Speakers at this event